Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6655)
All Articles published online
|
Publishing Process of This Article
|
Dec 20, 2018 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garg H, Hada RS, Gupta JC, Talwar GP, Dubey S. Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model. World J Clin Oncol 2018; 9(8): 188-199 [PMID: 30622927 DOI: 10.5306/wjco.v9.i8.188] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v9/i8/188.htm |
| Number | Citing Articles |
| 1 |
Kirsten Stefan, Ryan Gordon, Annah Rolig, Alexander Honkala, Dhanir Tailor, Lara E. Davis, Rajiv I. Modi, Manjul Joshipura, Bakulesh Khamar, Sanjay V. Malhotra. Mycobacterium w - a promising immunotherapeutic intervention for diseases. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1450118
|
| 2 |
Ambreen Rashid, Mohammad Azad, Anuja Krishnan, Jagdish C. Gupta, G.P. Talwar. Expression, purification and characterization of a novel triple fusion protein developed for the immunotherapy of survivin positive cancers. Protein Expression and Purification 2025; 226: 106614 doi: 10.1016/j.pep.2024.106614
|
| 3 |
Katrin Campbell, Vivienne L. Young, Braeden C. Donaldson, Matthew J. Woodall, Nicholas J. Shields, Greg F. Walker, Vernon K. Ward, Sarah L. Young. Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses. Vaccines 2021; 9(5): 463 doi: 10.3390/vaccines9050463
|
| 4 |
Sahar Dinparvar, Emrah Sefik Abamor, Sedanur Oztav, Tugba Gul Inci, Murat Ihlamur, Malahat Baghirova, Dilek Turgut-Balik, Adil M Allahverdiyev. Evaluation of in vitro immunostimulatory and cytotoxic effects of recombinant survivin protein in combination with doxorubicin and breast cancer antigen-loaded polycaprolactone nanoparticles. Nano Futures 2023; 7(3): 035001 doi: 10.1088/2399-1984/acde26
|
| 5 |
Qilai Cheng, Yingchen Li, Xiaohua Guo, Hongliang Li. Involvement of mTOR/Survivin signaling pathway in TUA(2β, 3β, 23-trihydroxy-urs-12-ene-28-olic acid)-induced apoptosis in human gastric cancer cell line BGC823 cells. Journal of Ethnopharmacology 2021; 267: 113437 doi: 10.1016/j.jep.2020.113437
|